Case Report: Tyrosine Kinase Inhibitors Induced Lymphadenopathy in Desmoid Tumor Patients

Tyrosine kinase inhibitors (TKIs) are nowadays a valuable treatment of desmoid tumors, a rare mesenchymal neoplasm. Although many side effects of imatinib and pazopanib, commonly or rarely occurring, have been described, reactional lymphadenopathy has not yet been reported. In this publication, we r...

Descripción completa

Detalles Bibliográficos
Autores principales: Papadopoulos, Sotirios, Koulouris, Pantelis, Royer-Chardon, Claire, Tsoumakidou, Georgia, Dolcan, Ana, Cherix, Stephane, Matter, Maurice, Omoumi, Patrick, Digklia, Antonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984282/
https://www.ncbi.nlm.nih.gov/pubmed/35399933
http://dx.doi.org/10.3389/fendo.2022.794512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984282/
https://www.ncbi.nlm.nih.gov/pubmed/35399933
http://dx.doi.org/10.3389/fendo.2022.794512

Ejemplares similares